A recently published study by FMI expects the global needle-free injectors market to augment at a 12% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 42.79 Billion is expected for the market. Faster drug delivery is the key driver for the needle-free injector market. Increasing d.
Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirms its guidance for its financial year 2022 after delivering
Gerresheimer AG is expanding its portfolio of highly-innovative platform technologies for drug delivery. Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma,
DGAP-Media / 09.05.2022 / 14:00 Gerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solution Partners are developing needle-free drug delivery platform for biologics and biosimilars This Innovative solution improves patient’s quality of life.